Literature DB >> 29949391

Increased megalin expression in early type 2 diabetes: role of insulin-signaling pathways.

Mark A Bryniarski1, Benjamin M Yee1, Irum Jaffri1, Lee D Chaves2, Jin Ah Yu1, Xiaowen Guan1, Nazanin Ghavam1, Rabi Yacoub2, Marilyn E Morris1.   

Abstract

The megalin/cubilin complex is responsible for the majority of serum protein reclamation in the proximal tubules. The current study examined if decreases in their renal expression, along with the albumin recycling protein neonatal Fc receptor (FcRn) could account for proteinuria/albuminuria in the Zucker diabetic fatty rat model of type 2 diabetes. Immunoblots of renal cortex samples obtained at worsening disease stages demonstrated no loss in megalin, cubilin, or FcRn, even when proteinuria was measured. Additionally, early diabetic rats exhibited significantly increased renal megalin expression when compared with controls (adjusted P < 0.01). Based on these results, the ability of insulin to increase megalin was examined in a clonal subpopulation of the opossum kidney proximal tubule cell line. Insulin treatments (24 h, 100 nM) under high glucose conditions significantly increased megalin protein ( P < 0.0001), mRNA ( P < 0.0001), and albumin endocytosis. The effect on megalin expression was prevented with inhibitors against key effectors of insulin intracellular signaling, phosphatidylinositide 3-kinase and Akt. Studies using rapamycin to inhibit the mechanistic target of rapamycin complex 1 (mTORC1) resulted in a loss of insulin-induced megalin expression. However, subsequent evaluation demonstrated these effects were independent of initial mTORC1 suppression. The presented results provide insight into the expression of megalin, cubilin, and FcRn in type 2 diabetes, which may be impacted by elevated insulin and glucose. Furthermore, proximal tubule endocytic activity in early diabetics may be enhanced, a process that could have a significant role in proteinuria-induced renal damage.

Entities:  

Keywords:  cubilin; diabetic nephropathy; megalin

Mesh:

Substances:

Year:  2018        PMID: 29949391     DOI: 10.1152/ajprenal.00210.2018

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  8 in total

1.  Proximal tubular epithelial insulin receptor mediates high-fat diet-induced kidney injury.

Authors:  Hak Joo Lee; Meenalakshmi M Mariappan; Luke Norton; Terry Bakewell; Denis Feliers; Sae Byeol Oh; Andrew Donati; Cherubina S Rubannelsonkumar; Manjeri A Venkatachalam; Stephen E Harris; Isabelle Rubera; Michel Tauc; Goutam Ghosh Choudhury; C Ronald Kahn; Kumar Sharma; Ralph A DeFronzo; Balakuntalam S Kasinath
Journal:  JCI Insight       Date:  2021-02-08

2.  Interference with megalin expression/endocytic function by montelukast mitigates gentamicin nephrotoxicity: Downregulation of ClC-5 expression.

Authors:  Amany A Azouz; Dina A Hanna; Ali A Abo-Saif; Basim Anwar Shehata Messiha
Journal:  Saudi Pharm J       Date:  2022-01-04       Impact factor: 4.562

3.  IgG subclass deposition in diabetic nephropathy.

Authors:  Xuanli Tang; Feng Wan; Qin Zhu; Tian Ye; Xue Jiang; Haichun Yang
Journal:  Eur J Med Res       Date:  2022-08-11       Impact factor: 4.981

4.  Drug-drug interaction between diclofenac and gamma-hydroxybutyric acid.

Authors:  Vivian Rodriguez-Cruz; Tianjing Ren; Marilyn E Morris
Journal:  Biopharm Drug Dispos       Date:  2021-07-08       Impact factor: 1.831

Review 5.  Insulin receptors in the kidneys in health and disease.

Authors:  Sarojini Singh; Rajni Sharma; Manju Kumari; Swasti Tiwari
Journal:  World J Nephrol       Date:  2019-01-21

6.  Effect of Insulin on Proximal Tubules Handling of Glucose: A Systematic Review.

Authors:  Ricardo Pereira-Moreira; Elza Muscelli
Journal:  J Diabetes Res       Date:  2020-01-10       Impact factor: 4.011

7.  The sodium-glucose cotransporter 2 inhibitor tofogliflozin prevents diabetic kidney disease progression in type 2 diabetic mice.

Authors:  Zi Li; Maki Murakoshi; Saki Ichikawa; Takeo Koshida; Eri Adachi; Chigure Suzuki; Seiji Ueda; Tomohito Gohda; Yusuke Suzuki
Journal:  FEBS Open Bio       Date:  2020-11-10       Impact factor: 2.693

Review 8.  Current Challenges and Future Perspectives of Renal Tubular Dysfunction in Diabetic Kidney Disease.

Authors:  Suyan Duan; Fang Lu; Dandan Song; Chengning Zhang; Bo Zhang; Changying Xing; Yanggang Yuan
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-10       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.